Active Ingredient: PATISIRAN SODIUM
Proprietary Name: ONPATTRO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 10MG BASE/5ML (EQ 2MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210922
Product Number: 001
Approval Date: Aug 10, 2018
Applicant Holder Full Name: ALNYLAM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
